FasTCAR Cell Therapy Granted Orphan Drug Designation for Multiple Myeloma
The designation follows durable responses seen in a phase 1 study of the agent.
TIL Adoptive Cell Therapy for the Treatment of mNSC Lung Cancer
A new TIL therapy seeks to improve on current treatments for metastatic non-small cell lung cancer such as PD-1 inhibitors.
Autologous Hematopoietic Stem Cell Transplant Shows Durable Response in Mantle Cell Lymphoma
A post-hoc analysis overviewed long-term efficacy of autologous hematopoietic stem cell transplantation in mantle cell lymphoma.
iPSC-Derived NK Cell Agents Show Benefit in B-Cell Malignancies
FT516 and FT595 are both currently being evaluated in phase 1 trials for B-cell malignancies.
First Study of CAR T in R/R Thyroid Cancer Underway
The non-randomized, open-label trial of AIC100 is currently recruiting patients at the Weill Cornell Medical College in in New York.
First Patient Dosed in Trial of GEN-011 for Treating Solid Tumors
The TiTAN-1 clinical trial is assessing the effect of GEN-011 on melanoma and various types of carcinomas.
Best Practices With CAR T-Cell Therapy Being Refined in Lymphomas
Alison R. Sehgal, MD, discusses the latest developments with CAR T-cell therapy in lymphomas.